ProfileGDS4718 / 208228_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 85% 91% 65% 66% 33% 55% 79% 84% 75% 71% 75% 32% 51% 41% 75% 72% 43% 69% 41% 46% 70% 79% 58% 61% 59% 65% 27% 80% 58% 79% 59% 86% 80% 43% 53% 35% 73% 81% 89% 88% 61% 66% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3443863
GSM549102patient 115, normal, homogenized [OPG study]8.4451485
GSM549104patient 119, normal, homogenized [OPG study]9.3829491
GSM549108patient 138, normal, homogenized [OPG study]6.5033265
GSM549119patient 077, normal, homogenized [OPG study]6.5273366
GSM549133patient 032, cancer, homogenized [OPG study]4.5954933
GSM549139patient 042, cancer, homogenized [OPG study]5.7644355
GSM549099patient 107, normal, homogenized [OPG study]7.6908579
GSM549109patient 139, normal, homogenized [OPG study]8.3053784
GSM549110patient 046, normal, homogenized [OPG study]7.2931375
GSM549114patient 063, normal, homogenized [OPG study]6.9734571
GSM549122patient 082, normal, homogenized [OPG study]7.3563975
GSM549134patient 033, cancer, homogenized [OPG study]4.5986632
GSM549136patient 036, cancer, homogenized [OPG study]5.4951451
GSM549140patient 044, cancer, homogenized [OPG study]5.0136641
GSM549111patient 047, normal, homogenized [OPG study]7.3874875
GSM549113patient 057, normal, homogenized [OPG study]7.0827772
GSM549132patient 031, cancer, homogenized [OPG study]5.1170343
GSM549137patient 038, cancer, homogenized [OPG study]6.7779869
GSM549142patient 047, cancer, homogenized [OPG study]5.178241
GSM549100patient 110, normal, homogenized [OPG study]5.3408746
GSM549107patient 135, normal, homogenized [OPG study]6.9119270
GSM549115patient 068, normal, homogenized [OPG study]7.8241379
GSM549116patient 072, normal, homogenized [OPG study]6.0104758
GSM549120patient 078, normal, homogenized [OPG study]6.1711761
GSM549131patient 030, cancer, homogenized [OPG study]6.0058859
GSM549118patient 074, normal, homogenized [OPG study]6.4568965
GSM549129patient 027, cancer, homogenized [OPG study]4.4407927
GSM549123patient 088, normal, homogenized [OPG study]7.8952280
GSM549124patient 006, cancer, homogenized [OPG study]5.99958
GSM549126patient 015, cancer, homogenized [OPG study]7.7986379
GSM549128patient 025, cancer, homogenized [OPG study]6.0667559
GSM549103patient 117, normal, homogenized [OPG study]8.4004486
GSM549117patient 073, normal, homogenized [OPG study]7.8469380
GSM549138patient 041, cancer, homogenized [OPG study]5.1055843
GSM549141patient 045, cancer, homogenized [OPG study]5.6459753
GSM549130patient 028, cancer, homogenized [OPG study]4.779135
GSM549101patient 111, normal, homogenized [OPG study]7.1223173
GSM549105patient 128, normal, homogenized [OPG study]7.9683681
GSM549106patient 134, normal, homogenized [OPG study]9.1772789
GSM549112patient 048, normal, homogenized [OPG study]9.0051288
GSM549125patient 011, cancer, homogenized [OPG study]6.2232161
GSM549127patient 024, cancer, homogenized [OPG study]6.6273466
GSM549135patient 035, cancer, homogenized [OPG study]4.8415938